143 related articles for article (PubMed ID: 33833588)
1. Psychometric Testing of the Japanese Version of the Daily Record of Severity of Problems Among Japanese Women.
Takeda T; Kai S; Yoshimi K
Int J Womens Health; 2021; 13():361-367. PubMed ID: 33833588
[TBL] [Abstract][Full Text] [Related]
2. The Japanese Version of the Daily Record of Severity of Problems for Premenstrual Symptoms: Reliability and Validity Among the General Japanese Population.
Takeda T; Yoshimi K; Kai S; Inoue F
Int J Womens Health; 2024; 16():299-308. PubMed ID: 38435757
[TBL] [Abstract][Full Text] [Related]
3. The reliability and validity of the Japanese version of the Daily Record of Severity of Problems (J-DRSP) and Development of a Short-Form version (J-DRSP (SF)) to assess symptoms of premenstrual syndrome among Japanese women.
Ikeda Y; Egawa M; Okamoto K; Mandai M; Takahashi Y; Nakayama T
Biopsychosoc Med; 2021 Mar; 15(1):6. PubMed ID: 33736660
[TBL] [Abstract][Full Text] [Related]
4. Psychometric Testing of the Premenstrual Symptoms Questionnaire and the Association Between Perceived Injustice and Premenstrual Symptoms: A Cross-Sectional Study Among Japanese High School Students.
Takeda T; Yoshimi K; Yamada K
Int J Womens Health; 2020; 12():755-763. PubMed ID: 33061664
[TBL] [Abstract][Full Text] [Related]
5. Development of a Japanese Version of the Daily Record of Severity of Problems for Diagnosing Premenstrual Syndrome.
Ikeda Y; Egawa M; Hiyoshi K; Ueno T; Ueda K; Becker CB; Takahashi Y; Nakayama T; Mandai M
Womens Health Rep (New Rochelle); 2020; 1(1):11-16. PubMed ID: 33786468
[No Abstract] [Full Text] [Related]
6. Development and Psychometric Testing of a New Short-Form of the Premenstrual Symptoms Questionnaire (PSQ-S).
Takeda T; Yoshimi K; Kai S; Inoue F
Int J Womens Health; 2022; 14():899-911. PubMed ID: 35860717
[TBL] [Abstract][Full Text] [Related]
7. Correction to: The reliability and validity of the Japanese version of the daily record of severity of problems (J-DRSP) and development of a short-form version (J-DRSP (SF)) to assess symptoms of premenstrual syndrome among Japanese women.
Ikeda Y; Egawa M; Okamoto K; Mandai M; Takahashi Y; Nakayama T
Biopsychosoc Med; 2021 Dec; 15(1):27. PubMed ID: 34972535
[No Abstract] [Full Text] [Related]
8. Daily Record of Severity of Problems (DRSP): reliability and validity.
Endicott J; Nee J; Harrison W
Arch Womens Ment Health; 2006 Jan; 9(1):41-9. PubMed ID: 16172836
[TBL] [Abstract][Full Text] [Related]
9. Chinese version of Daily Record of Severity of Problems: reliability and validity.
Wu L; He Z; Zhao H; Ma D; Zhang S; Deng H; Liang T
J Adv Nurs; 2013 Feb; 69(2):449-56. PubMed ID: 22737971
[TBL] [Abstract][Full Text] [Related]
10. Treatment of premenstrual dysphoric disorder with the GABA
Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
[TBL] [Abstract][Full Text] [Related]
11. Assessment of premenstrual symptoms: validation of the Italian version of the Premenstrual Symptoms Screening Tool.
Pacitti F; Iorio C; Riccobono G; Iannitelli A; Pompili A
Riv Psichiatr; 2021; 56(5):246-253. PubMed ID: 34663991
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of ethinylestradiol/drospirenone for premenstrual symptoms in Japanese patients with dysmenorrhea: Open-label pilot study.
Takeda T; Kondo A; Koga S; Hayakawa J; Hayakawa K; Hiramatsu K; Yaegashi N
J Obstet Gynaecol Res; 2015 Oct; 41(10):1584-90. PubMed ID: 26310836
[TBL] [Abstract][Full Text] [Related]
13. Premenstrual Syndrome Diagnosis: A Comparative Study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST).
Henz A; Ferreira CF; Oderich CL; Gallon CW; Castro JRS; Conzatti M; Fleck MPA; Wender MCO
Rev Bras Ginecol Obstet; 2018 Jan; 40(1):20-25. PubMed ID: 29132173
[TBL] [Abstract][Full Text] [Related]
14. Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial.
Comasco E; Kopp Kallner H; Bixo M; Hirschberg AL; Nyback S; de Grauw H; Epperson CN; Sundström-Poromaa I
Am J Psychiatry; 2021 Mar; 178(3):256-265. PubMed ID: 33297719
[TBL] [Abstract][Full Text] [Related]
15. The Chinese version of the Perceived Stress Questionnaire: development and validation amongst medical students and workers.
Meng R; Li J; Wang Z; Zhang D; Liu B; Luo Y; Hu Y; Yu C
Health Qual Life Outcomes; 2020 Mar; 18(1):70. PubMed ID: 32169070
[TBL] [Abstract][Full Text] [Related]
16. Validity and reliability of the Japanese version of the Patient Satisfaction Questionnaire (PSQ-J) for evaluating oncologist consultations.
Kamo Y; Fujimori M; Asai M; Oishi T; Mori M; Miyashita M; Morita T; Uchitomi Y
PEC Innov; 2023 Dec; 2():100166. PubMed ID: 37384155
[TBL] [Abstract][Full Text] [Related]
17. Translation and Validation of the Premenstrual Assessment Form-Short Form Questionnaire in Hungarian.
Dózsa-Juhász O; Makai A; Prémusz V; Ács P; Hock M
Womens Health Rep (New Rochelle); 2024; 5(1):286-292. PubMed ID: 38558945
[TBL] [Abstract][Full Text] [Related]
18. A DSM-5-based tool to monitor concurrent mood and premenstrual symptoms: the McMaster Premenstrual and Mood Symptom Scale (MAC-PMSS).
Frey BN; Allega OR; Eltayebani M; Syan SK; Mendes-Ribeiro J; Minuzzi L
BMC Womens Health; 2022 Mar; 22(1):96. PubMed ID: 35354450
[TBL] [Abstract][Full Text] [Related]
19. The Female Sexual Function Index (FSFI): development of a Japanese version.
Takahashi M; Inokuchi T; Watanabe C; Saito T; Kai I
J Sex Med; 2011 Aug; 8(8):2246-54. PubMed ID: 21492402
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder.
Bäckström T; Ekberg K; Hirschberg AL; Bixo M; Epperson CN; Briggs P; Panay N; O'Brien S
Psychoneuroendocrinology; 2021 Nov; 133():105426. PubMed ID: 34597899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
